|
JOSD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.77160000014842E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.12089995460718E-09 |
| Normal-vs-Stage2 |
1.364250E-02 |
| Normal-vs-Stage3 |
2.086000E-02 |
| Normal-vs-Stage4 |
5.859200E-03 |
| Stage1-vs-Stage2 |
1.188350E-01 |
| Stage1-vs-Stage3 |
2.799600E-04 |
| Stage1-vs-Stage4 |
2.793800E-02 |
| Stage2-vs-Stage3 |
3.775000E-01 |
| Stage2-vs-Stage4 |
8.086200E-01 |
| Stage3-vs-Stage4 |
4.654800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.81599999949623E-07 |
| Normal-vs-AfricanAmerican |
6.615700E-03 |
| Normal-vs-Asian |
4.417600E-02 |
| Caucasian-vs-AfricanAmerican |
8.561400E-01 |
| Caucasian-vs-Asian |
7.864200E-01 |
| AfricanAmerican-vs-Asian |
8.938000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11469999999991E-05 |
| Normal-vs-Female |
3.23820000036612E-07 |
| Male-vs-Female |
8.301600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.798200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.95139999948202E-07 |
| Normal-vs-Age(61-80Yrs) |
2.37669999999524E-05 |
| Normal-vs-Age(81-100Yrs) |
1.103850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.734000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.115200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.322600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.576400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.884400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.771400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.016000E-03 |
| Normal-vs-Grade 2 |
4.14709999674301E-09 |
| Normal-vs-Grade 3 |
1.315770E-03 |
| Normal-vs-Grade 4 |
2.526100E-02 |
| Grade 1-vs-Grade 2 |
4.157500E-02 |
| Grade 1-vs-Grade 3 |
1.764020E-03 |
| Grade 1-vs-Grade 4 |
2.998100E-03 |
| Grade 2-vs-Grade 3 |
1.164620E-03 |
| Grade 2-vs-Grade 4 |
7.820400E-03 |
| Grade 3-vs-Grade 4 |
7.551200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.0927003746275E-10 |
| Normal-vs-ccB subtype |
1.165800E-02 |
| ccA subtype-vs-ccB subtype |
2.75940000005193E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.63159999999807E-05 |
| Normal-vs-N1 |
8.859600E-02 |
| N0-vs-N1 |
6.859000E-01 |
|
|
